title: Edaravone may be an efficacious adjunctive therapeutic agent for decompression sickness: an editorial perspective.
authors.forename: Guoyang
authors.initials: G
authors.lastname: Huang
authors.forename: Weigang
authors.initials: W
authors.lastname: Xu
mesh_terms: D000818:Animals; D000983:Antipyrine / Q000031:analogs & derivatives* / Q000494:pharmacology; D002448:Cell Adhesion / Q000187:drug effects; D016207:Cytokines / Q000378:metabolism; D003665:Decompression Sickness / Q000188:drug therapy* / Q000209:etiology; D000077553:Edaravone; D016166:Free Radical Scavengers / Q000494:pharmacology*; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism; D009504:Neutrophils / Q000276:immunology / Q000378:metabolism; D052250:Nitric Oxide Synthase Type III / Q000378:metabolism; D018384:Oxidative Stress / Q000187:drug effects; D015854:Up-Regulation / Q000187:drug effects
chemical_list: D016207:Cytokines; D016166:Free Radical Scavengers; D018836:Inflammation Mediators; D052250:Nitric Oxide Synthase Type III; D000077553:Edaravone; D000983:Antipyrine